Skip to main content

What the FDA labels say about taking them together

Efavirenz and letermovir

Letermovir's FDA label of January 14, 2026 names efavirenz in its drug interactions section; the efavirenz label PlainMeds reads does not name letermovir. The letermovir label: “Co-administration of PREVYMIS and efavirenz is not recommended due to potential for loss of efficacy of PREVYMIS.”

Check it at the source: the efavirenz FDA label on DailyMed (effective March 31, 2024, Cipla USA Inc.); the letermovir FDA label on DailyMed (effective January 14, 2026, Merck Sharp & Dohme LLC).

What does the efavirenz label say about letermovir?

Efavirenz's label (effective March 31, 2024) does not name letermovir in these sections. A label lists what its studies and reports found; it is not a complete list.

Source: FDA drug label (Efavirenz), Cipla USA Inc., effective March 31, 2024 (SPL set 92603fa5-7a2c-4bfb-9a70-aadb4fba952c), via openFDA; the full label on DailyMed

What does the letermovir label say about efavirenz?

Letermovir label, drug interactions

Concomitant Drug Class and/or Clearance Pathway/Drug Name: efavirenz; Effect on Concentration ↓ =decrease, ↑ =increase: ↓ letermovir; Clinical Comments: Co-administration of PREVYMIS and efavirenz is not recommended due to potential for loss of efficacy of PREVYMIS.

Source: FDA drug label (PREVYMIS), Merck Sharp & Dohme LLC, effective January 14, 2026 (SPL set 1b49df80-be4f-47e0-a0b7-123f3e69395b), via openFDA; the full label on DailyMed

These are the labels' own sentences. PlainMeds does not grade interactions; a pharmacist or prescriber can say what they mean for one person's medicines.

Both medicines on the record

5Efavirenz generic labelers
0Letermovir generic labelers
EfavirenzLetermovir
Labeled forHIVn/a
Boxed warningNoNo
Pharmacy cost (NADAC)$1.28 per tablet 600 mg tabletn/a
Shortage nowNo current entryNo current entry

Source: FDA NDC Directory, CMS NADAC of October 7, 2026 and the FDA Drug Shortage Database (FDA files October 8, 2026)

What next?